WearLinq is the developer of eWave, the first and only 6-lead wireless cardiac monitor. eWave is FDA 510(k)-cleared and used across thousands of patients. WearLinq is backed by AIX Ventures, SpringTide, Berkeley Catalyst Fund, Lightscape Partners, Amino Capital, and other leading investors. Wearlinq's eWave is the first continuous, multi-lead (6-lead) ECG in a small, wireless form factor that patients will actually wear. It's the only continuous cardiac monitor that pairs with the patient's personal phone, runs for 5+ days between charges, and delivers near-real-time data and reports to clinicians.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
12/17/25	$14,000,000	Series A	AIX Ventures Alumni Ventures Group Amino Capital Angelschool Berkeley Catalyst Fund Celtic House Device of Tomorrow Capital LDV Partners Lightscape Partners Maliam NYX Ventures Partners SmartLink Partners Solasta Ventures SpringTide Investments XB Ventures	undisclosed